KZA 0.00% 8.0¢ kazia therapeutics limited

nrt should go to about 6.60, page-4

  1. 3,567 Posts.
    I know Yale are making a presentation at AACR regarding Phenoxodiol. Exactly what is to be covered is anyone's guess... I'm tipping we'll see some "added" content that might have been cancelled at ASCO. We know one was cancelled but we don't know exactly what was inthat one either due to the lack of an abstract... not much help am I.

    But still, Novogen should get some nice media coverage in the days/weeks after AACR. It's quite a large conference and Dr Mor could surprise us and present interim results for the ovarian cancer trial.

    We Already know that Yale has seen stabilisation and regression of cancer in the lower dose patients.

    I'm long.

    Cheers,
    Munch.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.